ストックスクリーナーアプリを入手
25.86
2.75%
-0.73
アフターアワーズ：
25.86
Mineralys Therapeutics Inc (MLYS) 最新ニュース
Form 4 Mineralys Therapeutics Inc For: 24 September By Investing.com - Investing.com Canada
Mineralys Therapeutics director sells $3 million in shares By Investing.com - Investing.com Nigeria
Mineralys Therapeutics director sells $3 million in shares - Investing.com
A fund sold Mineralys (MLYS) shares and still holds more than 7.8 million. - Stock Titan
Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - GlobeNewswire
Mineralys to present lorundrostat trial data at AHA meeting By Investing.com - Investing.com Canada
Mineralys to present lorundrostat trial data at AHA meeting - Investing.com India
Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026 - The Manila Times
Long-term results for a blood pressure drug will be presented at an American Heart Association meeting - Stock Titan
Form 144 Mineralys Therapeutics For: 23 September By Investing.com - Investing.com Nigeria
Form 144 Mineralys Therapeutics For: 23 September - Investing.com India
Form 4 Mineralys Therapeutics Inc For: 22 September - Investing.com India
Mineralys Therapeutics CCO Eric Warren sells $209k in stock - Investing.com India
Mineralys Therapeutics CCO Eric Warren sells $209k in stock By Investing.com - Investing.com Nigeria
Form 4 Mineralys Therapeutics Inc For: 22 September By Investing.com - Investing.com Nigeria
Fund may sell Mineralys (NASDAQ: MLYS) shares; filing shows the size - Stock Titan
(MLYS) Risk Channels and Responsive Allocation - Stock Traders Daily
Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Promising 71% Upside Potential In Biotech - DirectorsTalk Interviews
Mineralys Therapeutics, Inc. (MLYS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Mineralys Therapeutics (MLYS) officer lines up new stock option sale - Stock Titan
A new employee gets Mineralys stock awards covering 14,880 and 11,160 shares - Stock Titan
Mineralys Therapeutics (MLYS) CCO sells 7,438 shares in pre-set plan - Stock Titan
Mineralys Therapeutics director Karydas sells $85,740 in stock By Investing.com - Investing.com Canada
Mineralys Therapeutics director Karydas sells $85,740 in stock - Investing.com
Mineralys Therapeutics (MLYS) director sells shares under preset plan - Stock Titan
Mineralys Therapeutics (NASDAQ: MLYS) executive plans new stock option sale after recent $388K trade - Stock Titan
Mineralys (NASDAQ: MLYS) officer to sell 3,000 shares via options - Stock Titan
Mineralys Grants Equity Awards to Two New Employees - mychesco.com
Mineralys (MLYS) officer to sell 7,709 shares - Stock Titan
Understanding the Setup: (MLYS) and Scalable Risk - Stock Traders Daily
Mineralys Therapeutics grants inducement equity awards covering 52,080 shares to new hires - Bitget
Mineralys at Wells Fargo conference: lorundrostat launch takes shape By Investing.com - Investing.com Canada
MLYS: Lorundrostat nears approval with strong data, broad market prep, and a focus on parity access - TradingView
Mineralys Therapeutics (NASDAQ: MLYS) insider to sell 2,171 shares via cashless option exercise - Stock Titan
Two new hires get four-year stock awards from Mineralys - Stock Titan
Mineralys Therapeutics Market Sentiment - Benzinga España
BEAM Stock Price and Chart — NASDAQ:BEAM - TradingView
Mineralys Therapeutics upgraded to Buy ahead of lorundrostat FDA approval and strong market launch. - Pluang
Mineralys: Why I'm Making Stock A Buy Ahead Of Hypertension Approval Decision (MLYS) - Seeking Alpha
Wells Fargo healthcare conference puts Mineralys management on Sept. 9 agenda - Stock Titan
Mineralys Therapeutics CCO Eric Warren sells $193,188 in shares By Investing.com - Investing.com Nigeria
Mineralys (NASDAQ: MLYS) CCO sells 7,437 shares under 10b5-1 plan - Stock Titan
Mineralys (MLYS) Session: Loses 0.39% to Close at $25.65 in Latest Trading; Range Check: the Session Ends Within the Reported Technical BoundariesSkew Index - careplusvn.com
Mineralys (NASDAQ: MLYS) insider plans sale after $2,696,321.98 June stock deal - Stock Titan
Mineralys Plunges As Costly Royalty Deal Shocks Wall Street - TipRanks
People on the Move: Jessica Wagner Keliher, SPHR, Joins Mineralys Therapeutics as Vice President, Talent Management - BioBuzz
Timothy G. Youngquist 2020 Irrevocable Trust Takes $2.72 Million Position in Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Mineralys (MLYS) Q2 2026 Earnings Call Transcript - AOL.com
Mineralys Builds $661 Million War Chest Ahead of FDA Decision - MyChesCo
Mineralys Grants Equity Awards to New Medical Chief - MyChesCo
TimesSquare Capital Management LLC Invests $6.36 Million in Mineralys Therapeutics, Inc. $MLYS - MarketBeat
Mineralys (NASDAQ: MLYS) insider adds 417-share sale to six-figure run - Stock Titan
Mineralys Therapeutics, Inc. $MLYS Shares Bought by Bank of America Corp DE - MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Downgraded by Zacks Research to "Strong Sell" - MarketBeat
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):